Journal article
Cystic fibrosis related diabetes: Medical management
Journal of cystic fibrosis, Vol.18, pp.S10-S18
10/01/2019
DOI: 10.1016/j.jcf.2019.08.003
PMID: 31679720
Abstract
Cystic Fibrosis Related Diabetes Mellitus (CFRD) drives excess pulmonary morbidity and mortality in patients with cystic fibrosis (CF). The recommended treatment is insulin therapy. Insulin therapy in CF should be customized to the specific patient. CF patients typically require intensive insulin regimens such as multiple daily injections or insulin pump therapy, but frequently require lower doses than in type 1 diabetes mellitus. Patients with CF may also need insulin to cover intravenous or enteral feedings. Pre-diabetic glycaemic abnormalities are also associated with clinical decline in cystic fibrosis prior to the diagnosis of CFRD, however, whether and how this should be treated is not fully determined. There is also interest, but inadequate data regarding other treatments besides insulin (i.e., oral medications) for treatment of pre-diabetes or CFRD. CFTR potentiator and corrector therapy has yet to demonstrate an effect on the rate of CFRD, but may improve insulin secretion. There is great opportunity for further research to better understand when and how best to treat glycaemic abnormalities in cystic fibrosis. (C) 2019 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
Details
- Title: Subtitle
- Cystic fibrosis related diabetes: Medical management
- Creators
- Katie Larson Ode - University of IowaChristine L. Chan - Children's Hospital ColoradoAndrea Granados - Washington University in St. LouisAmir Moheet - University of MinnesotaAntoinette Moran - University of MinnesotaAmanda L. Brennan - Wythenshawe Hospital
- Resource Type
- Journal article
- Publication Details
- Journal of cystic fibrosis, Vol.18, pp.S10-S18
- DOI
- 10.1016/j.jcf.2019.08.003
- PMID
- 31679720
- NLM abbreviation
- J Cyst Fibros
- ISSN
- 1569-1993
- eISSN
- 1873-5010
- Publisher
- Elsevier
- Number of pages
- 9
- Grant note
- Cystic Fibrosis Foundation, Emerging Leaders in CF Endocrinology (EnVision) Program
- Language
- English
- Date published
- 10/01/2019
- Academic Unit
- Endocrinology and Diabetes; Stead Family Department of Pediatrics
- Record Identifier
- 9984354505302771
Metrics
12 Record Views